Dr. Breelyn A. Wilky, MD is a sarcoma medical oncologist and clinical trialist at the University of Colorado Anschutz Medical Campus in Aurora, Colorado. She is part of a large multidisciplinary sarcoma team including medical oncologists, surgeons, radiation oncologists, pediatric oncologists, pathologists, radiologists, and interventional radiologists who work together to provide comprehensive care for sarcoma patients. She spends her time taking care of patients over the age of 18 with all kinds of sarcomas and other bone and soft tissue tumors including desmoid fibromatosis, pigmented villonodular synovitis, gastrointestinal stromal tumors, and giant cell tumor of bone. She is also a translational researcher who conducts and designs clinical trials for sarcoma patients. She also works with laboratory researchers to translate the latest findings from bench research into early phase clinical trials. She is an expert not only in traditional chemotherapy treatments for sarcomas, but also at using modern technology such as gene sequencing and molecular profiling to identify out-of-the-box treatments particularly in targeted therapy. She is particularly interested in novel immunotherapy approaches for sarcomas.
Dr. Wilky received her undergraduate degree in Biology and Music from Bates College in Lewiston, Maine, and attended medical school at the University of Medicine and Dentistry of New Jersey – Robert Wood Johnson Medical School in Piscataway, New Jersey (now Rutgers Medical School.) She received her MD with Distinction in Research. She then completed the Osler internship and residency in Internal Medicine at The Johns Hopkins Hospital in Baltimore, Maryland, and stayed there to complete her fellowship in Medical Oncology. Prior to her role in Colorado, Dr. Wilky was Assistant Professor at the Sylvester Comprehensive Cancer Center at the University of Miami from 2013 to 2018. Her honors and awards include election to the Alpha Omega Alpha Honor Medical Society, a recipient of an ASCO/Conquer Cancer Foundation Young Investigator Award in 2012 for her work investigating DDX3 as a novel therapeutic target in Ewing Sarcoma, Outstanding Clinical Researcher of the Year for 2017 at Sylvester Comprehensive Cancer Center, and most recently is the recipient of an American Cancer Society Mentored Research Scholar Grant to further her research in understanding the role of the immune system in fighting sarcomas.
In her free time Dr. Wilky enjoys spending time with her husband Jason and dog Chaos, fishing and boating, hiking and off-roading, cooking, and traveling.
Contact information: University of Colorado Anschutz Medical Campus, 12801 E 17th Avenue Room 8117, 8th Floor, Aurora, CO 80045. Clinic: (720) 848-0300. New patient referrals (Erica Becker, PA-C): (720) 848-9395